SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 84 filers reported holding SERES THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 2.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,630,000 | -75.6% | 475,121 | -49.5% | 0.01% | -71.1% |
Q1 2022 | $6,694,000 | -37.7% | 940,131 | -27.1% | 0.04% | -37.5% |
Q4 2021 | $10,748,000 | +1563.8% | 1,290,297 | +5554.0% | 0.07% | +928.6% |
Q3 2020 | $646,000 | -42.3% | 22,821 | -90.3% | 0.01% | -41.7% |
Q2 2020 | $1,120,000 | +47.8% | 235,307 | +10.8% | 0.01% | +20.0% |
Q1 2020 | $758,000 | -34.1% | 212,379 | -36.3% | 0.01% | -9.1% |
Q4 2019 | $1,150,000 | +82.5% | 333,396 | +112.2% | 0.01% | +37.5% |
Q3 2019 | $630,000 | +170.4% | 157,133 | +117.4% | 0.01% | +166.7% |
Q2 2019 | $233,000 | -82.7% | 72,280 | -63.2% | 0.00% | -84.2% |
Q1 2019 | $1,349,000 | +113.1% | 196,383 | +40.2% | 0.02% | +72.7% |
Q4 2018 | $633,000 | -36.0% | 140,083 | +7.5% | 0.01% | -21.4% |
Q3 2018 | $989,000 | -17.6% | 130,283 | -6.6% | 0.01% | -26.3% |
Q2 2018 | $1,200,000 | +84.3% | 139,484 | +57.3% | 0.02% | +72.7% |
Q1 2018 | $651,000 | -28.1% | 88,684 | -0.6% | 0.01% | -31.2% |
Q4 2017 | $905,000 | – | 89,218 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |